Astria Therapeutics Stock Price on December 15, 2021
ATXS Stock | USD 13.60 0.07 0.52% |
Below is the normalized historical share price chart for Astria Therapeutics extending back to June 25, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Astria Therapeutics stands at 13.60, as last reported on the 28th of March, with the highest price reaching 13.89 and the lowest price hitting 12.83 during the day.
If you're considering investing in Astria Stock, it is important to understand the factors that can impact its price. Astria Therapeutics is somewhat reliable given 3 months investment horizon. Astria Therapeutics secures Sharpe Ratio (or Efficiency) of 0.19, which signifies that the company had a 0.19% return per unit of risk over the last 3 months. We have analyzed and interpolated thirty different technical indicators, which can help you to evaluate if expected returns of 1.07% are justified by taking the suggested risk. Use Astria Therapeutics Risk Adjusted Performance of 0.1418, mean deviation of 4.53, and Downside Deviation of 4.21 to evaluate company specific risk that cannot be diversified away.
At this time, Astria Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 31.6 M in 2024, whereas Capital Stock is likely to drop slightly above 52.8 M in 2024. . Price Earnings To Growth Ratio is likely to gain to 0.11 in 2024, whereas Price Earnings Ratio is likely to drop (3.33) in 2024. Astria Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of June 2015 | 200 Day MA 8.8333 | 50 Day MA 13.2857 | Beta 0.72 |
Astria |
Sharpe Ratio = 0.1946
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ATXS | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
5.5 actual daily | 48 52% of assets are more volatile |
Expected Return
1.07 actual daily | 21 79% of assets have higher returns |
Risk-Adjusted Return
0.19 actual daily | 15 85% of assets perform better |
Based on monthly moving average Astria Therapeutics is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Astria Therapeutics by adding it to a well-diversified portfolio.
Price Book 5.0262 | Book Value 3.602 | Enterprise Value 592 M | Enterprise Value Ebitda (8.73) | Shares Float 36.1 M |
Astria Therapeutics Valuation on December 15, 2021
It is possible to determine the worth of Astria Therapeutics on a given historical date. On December 15, 2021 Astria was worth 7.12 at the beginning of the trading date compared to the closed value of 6.4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Astria Therapeutics stock. Still, in general, we apply an absolute valuation method to find Astria Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Astria Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Astria Therapeutics' related companies.
Open | High | Low | Close | Volume | |
03/14/2022 | 7.12 | 7.12 | 6.31 | 6.40 | 33,576 |
6.22 | 6.77 | 6.22 | 6.61 | 8,570 |
Backtest Astria Therapeutics | | | Astria Therapeutics History | | | Astria Therapeutics Valuation | Next |
Astria Therapeutics Trading Date Momentum on December 15, 2021
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Astria Therapeutics Fundamentals Correlations and Trends
By evaluating Astria Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Astria Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Astria financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Astria Therapeutics Stock history
Astria Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Astria is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Astria Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Astria Therapeutics stock prices may prove useful in developing a viable investing in Astria Therapeutics
Last Reported | Projected for 2024 | ||
Common Stock Shares Outstanding | 30.1 M | 31.6 M | |
Net Loss | -46.7 M | -49 M |
Astria Therapeutics Quarterly Net Working Capital |
|
Astria Therapeutics Stock Technical Analysis
Astria Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Astria Therapeutics Period Price Range
Low | March 14, 2022 | High |
7.12 | 6.40 |
-0.72 | -10.11% |
Astria Therapeutics March 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Astria Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Astria Therapeutics shares will generate the highest return on investment. By undertsting and applying Astria Therapeutics stock market strength indicators, traders can identify Astria Therapeutics entry and exit signals to maximize returns
Astria Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Astria Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Astria Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Astria to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1418 | |||
Jensen Alpha | 1.05 | |||
Total Risk Alpha | 0.0764 | |||
Sortino Ratio | 0.2867 | |||
Treynor Ratio | 0.5894 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astria Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more information on how to buy Astria Stock please use our How to Invest in Astria Therapeutics guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Astria Stock analysis
When running Astria Therapeutics' price analysis, check to measure Astria Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astria Therapeutics is operating at the current time. Most of Astria Therapeutics' value examination focuses on studying past and present price action to predict the probability of Astria Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astria Therapeutics' price. Additionally, you may evaluate how the addition of Astria Therapeutics to your portfolios can decrease your overall portfolio volatility.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Transaction History View history of all your transactions and understand their impact on performance |
Is Astria Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astria Therapeutics. If investors know Astria will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astria Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.42) | Return On Assets (0.17) | Return On Equity (0.31) |
The market value of Astria Therapeutics is measured differently than its book value, which is the value of Astria that is recorded on the company's balance sheet. Investors also form their own opinion of Astria Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Astria Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astria Therapeutics' market value can be influenced by many factors that don't directly affect Astria Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Astria Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Astria Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astria Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.